Speakers

Jo Brewer

VP, Allogeneic Research

Adaptimmune

Anthony Colenburg

Director of Quality

Adicet Bio

Stewart Abbot

CSO

Adicet Bio

Michael West

Chief Executive Officer

AgeX Therapeutics

Mark Leonard

VP, Process & Product Development

Allogene Therapeutics

Minna Montgomery

Director, Product Development and Implementation

American Red Cross Direct Patient Care and Emerging Offerings

Peter Flynn

CTO

Artiva Biotherapeutics

Blake Aftab

VP, Preclinical & Translational Science

Atara Biotherapeutics

Manny Duenas

VP, Head of Global Market Access

Atara Biotherapeutics

Maksim Mamonkin

Assistant Professor

Baylor College of Medicine

Joy Aho

Senior Product Manager

Be The Match BioTherapies

Aura Mackenzie

Senior Director

Bluebird Bio

Olivier Godeaux

CMO

Bone Therapeutics

Elizabeth Garner

Principal Scientist

Caribou Biosciences

Arthur Stril

Vice President, Corporate Development

Cellectis

Elena Spanjaard

Head of Regulatory Affairs

Celyad

Luis Borges

CSO

Century Therapeutics

Demetrios Kalaitzidis

Director, ImmunoOncology

CRISPR Therapeutics

Kuldeep Singh Neote

VP, External Innovations

Eli Lilly

Oliver Nussbaumer

Head of Immunology

GammaDelta Therapeutics

Dominic Clarke

Global Head of Cell Therapy

HemaCare Corporation

Melinda Mata

Senior Scientist

Immatics

Lawrence Lamb

CSO

Incysus Therapeutics

Sicco Popma

CEO, President & Founder IO

Biosciences

Chris Bond

VP, Cellular Engineering

Kite Pharma

Andy Snowden

Senior Director, Process Development

Kite Pharma

Scott R. Burger, MD

Principal - Advanced Cell and Gene Therapy

LLC

Marcos Langtry

Head of Allogeneic Cell Therapy Commercial Development

Lonza Pharma & Biotech

Jean-François Chaubard

CTO

MaSTheCell

Tamara Laskowski

Senior Research Scientist, Immunotherapy

MD Anderson Center

Meisam Naeimi

Postdoctoral Fellow

Nationwide Children's Hospital

Hans Klingemann

VP, R&D

NantKwest

Guanglin Yu

Senior Scientist

Novartis

Matthias Von Herrath

Vice President and Senior Medical Officer, Global Chief Medical Office

Novo Nordisk

Sumithira Vasu

Associate Professor

The Ohio State University

Chris Heery

CMO

Precision BioSciences

Dan MacLeod

Head of Cell Therapy

Precision Biosciences

Jonathan Gilbert

Head of Business Development

SQZ Biotechnologies

Lan Cao

Senior Director, Head of Product Development & Global Program Leader, Cell Therapy

Takeda

Dario Gutierrez

VP, Discovery, Research & Innovation

TCR2 Therapeutics

Bruce Bunnell

Professor & Director

Tulane University of Louisiana

Evren Alici

CEO

Vycellix

Allison Hubel Professor

Mechanical Engineering, Director, Biopeservation Core Resource

University of Minnesota